1-8 of 8
Ajay K. Gopal
Close
Sort by
Journal Articles

Answering the “Doctor, can CAR-T therapy cause cancer?” question in clinic

Clinical Trials & Observations
Rahul Banerjee, Christina Poh, Alexandre V. Hirayama, Jordan Gauthier, Ryan D. Cassaday, Mazyar Shadman, Andrew J. Cowan, Brian G. Till, Damian J. Green, Hans-Peter Kiem, Ajay K. Gopal, David G. Maloney
Journal: Blood Advances
Blood Adv (2024) 8 (4): 895–898.
https://doi.org/10.1182/bloodadvances.2023012336
Published: 2024
Journal Articles

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

Clinical Trials & Observations
Ryan C. Lynch, Christina Poh, Chaitra S. Ujjani, Edus H. Warren, III, Stephen D. Smith, Mazyar Shadman, Karolyn Morris, Sydney Lee, Heather Rasmussen, Susan Ottemiller, Megan Shelby, Sarith Keo, Kaitlin Verni, David M. Kurtz, Ash A. Alizadeh, Jacob J. Chabon, Gregory J. Hogan, Andre Schulz, Ted Gooley, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2449–2458.
https://doi.org/10.1182/bloodadvances.2022009145
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Clinical Trials & Observations
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, III, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (5): 687–696.
https://doi.org/10.1182/bloodadvances.2022008628
Published: 2023
Includes: Supplemental data
Journal Articles

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis

Mehdi Hamadani, Ajay K. Gopal, Marcelo Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla, Stefan Ciurea, Jordan Gauthier, Vaibhav Agrawal, Natalie S. Grover, Lazaros Lekakis, Dipenkumar Modi, Parastoo B. Dahi, Megan M. Herr, P. Connor Johnson, Hamza Hashmi, Peiman Hematti, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2022) 6 (2): 486–494.
https://doi.org/10.1182/bloodadvances.2021005788
Published: 2022
Includes: Supplemental data
Journal Articles

Megadose 90 Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma

Clinical Trials & Observations
Victor A. Chow, Ryan D. Cassaday, Theodore A. Gooley, Stephen D. Smith, Brenda M. Sandmaier, Damian J. Green, Johnnie J. Orozco, Sherilyn A. Tuazon, Manuela Matesan, Darrell R. Fisher, David G. Maloney, Oliver W. Press, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2021) 6 (1): 37–45.
https://doi.org/10.1182/bloodadvances.2021005056
Published: 2021
Journal Articles

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

Clinical Trials & Observations
Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, Yolanda D. Tseng, Cameron J. Turtle, David G. Maloney, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4869–4872.
https://doi.org/10.1182/bloodadvances.2020002292
Published: 2020
Journal Articles

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

Mazyar Shadman, Jordan Gauthier, Kevin A. Hay, Jenna M. Voutsinas, Filippo Milano, Ang Li, Alexandre V. Hirayama, Mohamed L. Sorror, Sindhu Cherian, Xueyan Chen, Ryan D. Cassaday, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3062–3069.
https://doi.org/10.1182/bloodadvances.2019000593
Published: 2019
Journal Articles

Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation

Clinical Trials & Observations
Ang Li, Chris Davis, Qian Wu, Shan Li, Madeline F. Kesten, Leona A. Holmberg, Ajay K. Gopal, David A. Garcia
Journal: Blood Advances
Blood Adv (2017) 1 (12): 707–714.
https://doi.org/10.1182/bloodadvances.2017006130
Published: 2017